Peptide Science Desk

Does insurance cover peptides?

Approved drugs: sometimes. Research peptides: no.

Plans pay for drugs on their drug list. "Research use only" products are not prescription drugs.

By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts

Short answer: Sometimes, but only for FDA-approved peptide medicines, like Wegovy, Zepbound or Ozempic, and only if your plan lists the drug and you meet its rules. Peptides sold "for research use only," like BPC-157, are not prescription drugs, so they are not on insurance drug lists. Since July 1, 2026, Medicare pays for some weight-loss GLP-1 drugs for a $50 copay if you qualify.
A pharmacist in a white coat looks at a bottle of liquid medicine in front of shelves
A pharmacist checks a liquid medicine (1988 photo).Photo: Bill Branson, National Cancer Institute (NIH), public domain

Will insurance cover my peptide? Checker

2. What coverage do you have?

Turn on JavaScript to use the checker. The table below shows the same answers in short form.

Coverage is a money rule. It is not proof that a drug works or is safe. FDA status, proof and safety are rated separately on our peptide pages. We never share doses or link research-peptide sellers.

Questions to ask your plan

Call the number on your insurance card. Write down the date, the person's name and a reference number.

  1. Is this drug on your drug list (formulary)? Which tier?
  2. Do I need prior authorization? What papers does my doctor need to send?
  3. Is it covered for my reason (my diagnosis)?
  4. How much will I pay each month?
  5. Are there limits, like how many fills, or trying another drug first?
  6. If you say no, how do I appeal?

Quick table: who usually pays?

TypeFDA statusInsurance
Wegovy, Zepbound, FoundayoApproved for weightMaybe, if your plan covers weight drugs. Medicare: $50 Bridge if you qualify.
Ozempic, Mounjaro, RybelsusApproved for type 2 diabetesMaybe, for diabetes, if on your plan's list.
Forteo, Tymlos, Linzess, Trulance, Egrifta SV, VyleesiApproved for set usesMaybe, for the approved use, if on your plan's list.
Compounded GLP-1sNot approvedUnlikely. Medicare: bulk ingredients are not Part D drugs.
BPC-157, TB-500, other research peptidesNot approvedNo. They are not prescription drugs.

Checker rules and prices checked October 23, 2026. Not medical, legal or insurance advice. Checker sources: Medicare.gov: Weight-loss drugs and the Medicare GLP-1 Bridge · CMS: Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027) · CMS: Prescription Drug Benefit Manual, Chapter 6 (Part D drugs, medically accepted use, compounding) · HealthCare.gov glossary: Formulary · HealthCare.gov glossary: Preauthorization · HealthCare.gov: How to appeal an insurance company decision · IRS Publication 502: Medical and dental expenses · FDA: Concerns with unapproved GLP-1 drugs used for weight loss · NovoCare (maker): Wegovy cost and savings · Lilly (maker): Zepbound self-pay pricing information · Lilly (maker): Foundayo coverage and savings

Does insurance cover peptides?

  • Only some. A health plan pays for drugs on its drug list, called a formulary.
  • Approved peptide drugs can be on that list. Examples are Wegovy, Zepbound, Ozempic, Mounjaro and insulin.
  • Products sold "for research use only" are not prescription drugs. So they are not on drug lists.
  • Being covered is about rules, not about whether a peptide works or is safe. Those are separate questions.

Does insurance cover peptides for weight loss?

  • It depends on your plan. Some plans cover weight-loss drugs and some do not.
  • A plan may need a "prior authorization" first. That means the plan must agree the drug is medically needed before it pays.
  • HealthCare.gov says a prior authorization is not a promise the plan will pay.
  • Ask your plan if the drug is on its list, and what rules come with it.

Does Medicare cover Wegovy, Zepbound or Foundayo?

  • Yes, for some people, through the new Medicare GLP-1 Bridge. It runs from July 1, 2026 to December 31, 2027.
  • You pay $50 a month. It covers Wegovy (shot or pill), Foundayo, and the Zepbound KwikPen. It does not cover Zepbound vials or single-dose pens.
  • You may qualify if you are 18 or older and your BMI is 35 or more. A lower BMI can count if you also have certain health problems, like heart failure, high blood pressure that is not controlled, kidney disease, or a past heart attack or stroke.
  • If you have type 2 diabetes, sleep apnea or fatty liver disease, your regular Part D plan handles it instead.
  • The $50 does not count toward your Part D deductible or yearly limit, and Extra Help cannot lower it.

Does insurance cover compounded peptides or peptide clinics?

  • Usually not in a simple way. Compounded drugs are made by a pharmacy and are not FDA approved.
  • For Medicare, CMS says bulk powders used to make compounded drugs do not count as Part D drugs.
  • Ask a clinic if it takes insurance before you pay, and get a receipt that names the drug.
  • The FDA warns that unapproved and compounded GLP-1 drugs are not checked by the FDA for safety or quality before sale.

How much do peptides cost without insurance?

  • For approved drugs, the makers post cash prices. These are their prices on October 23, 2026, and you still need a prescription.
  • Zepbound vials: $299 to $449 a month from Lilly, depending on strength. Needles are extra.
  • Wegovy pill: from $149 a month. Wegovy pen: $199 for the first 2 fills for new patients through December 31, 2026, then $349 (NovoCare).
  • Foundayo pill: from $149 a month (Lilly).
  • We do not list prices for research peptides. We never link to research-peptide sellers.

Can I use my HSA or FSA for peptides?

  • Maybe, for prescribed drugs. The IRS says prescribed medicines count as medical costs.
  • For weight loss, the IRS says it counts only when it treats a disease a doctor found, like obesity or heart disease.
  • The IRS says drugs brought into the US illegally do not count.
  • Ask your HSA or FSA company before you buy.

What if my plan says no?

  • You can appeal. HealthCare.gov says you can ask the plan to look again (an internal appeal).
  • If it still says no, you can ask an outside group to decide (an external review).
  • Ask your doctor to send notes that show why you need the drug.

Coverage at a glance

FDA statusWho may payNotes
Wegovy, Zepbound, FoundayoApproved for weight (with rules)Some private plans; Medicare GLP-1 Bridge ($50) if you qualifyPrior authorization may be needed
Forteo, Tymlos, Linzess, Trulance, Egrifta SV, VyleesiFDA approved for set usesMaybe, for the approved use, if it is on your plan’s drug listAsk if you need prior authorization
Ozempic, MounjaroApproved for type 2 diabetesPlans that list it, for diabetesUse for weight alone may not be covered
Compounded semaglutide or tirzepatideNot FDA approvedUsually cashMedicare: bulk ingredients are not Part D drugs
BPC-157, TB-500 and other "research" peptidesNot FDA approvedNot on drug listsNo approved drug to bill. Pharmacy-made versions under the Oct 28, 2026 HHS policy are compounded drugs (see the row above).
Check any peptide in 1 secondFree FDA Status Checker: approved, being tested, or not proven.

FAQ

Does Medicaid cover Wegovy or Zepbound?

It depends on your state. Call your state Medicaid office or check your member handbook.

Do savings cards work with Medicare?

The Wegovy and Foundayo savings cards for insured people exclude government plans like Medicare. The Medicare Bridge is separate.

Does cash paid to a maker count toward my deductible?

NovoCare says self-pay money does not count toward your insurance deductible. Ask your plan to be sure.

Will insurance pay for Ozempic for weight loss?

Ozempic is approved for type 2 diabetes. Plans may not pay when it is used for weight alone. Ask your plan.

What should I write down when I call my plan?

The date, the name of the person you spoke with, and any reference number. It helps if you need to appeal.

Is insurance coverage a sign a peptide works?

No. Coverage is a money rule. FDA approval is the best sign that a drug works and is safe for its labeled use.

Does the Medicare GLP-1 Bridge cover Ozempic?

No. The Bridge lists Wegovy, Foundayo and the Zepbound KwikPen. Ozempic for diabetes goes through your regular Part D plan.

Why does BPC-157 always show "No" in the checker?

It is not an FDA-approved prescription drug, so there is nothing for a plan to list. That alone does not tell you whether it works.

Is the checker connected to my insurance plan?

No. It uses public rules only. It runs in your browser, and we do not store your choices. Only your plan can say for sure what it pays for.

Where do the prices come from?

From the drug makers’ own pages for FDA-approved drugs, checked October 23, 2026. Prices can change at any time.

When does Medicare open enrollment end for 2027 plans?

October 15 to December 7, 2026, for coverage that starts January 1, 2027. Medicare.gov says the plan must get your request by December 7. The Medicare GLP-1 Bridge ($50 a month for Foundayo, Wegovy and the Zepbound KwikPen, if you qualify) continues through December 31, 2027 outside Part D, so you do not need a new plan only to keep Bridge access — but you still need eligible Part D coverage. Before you switch, check whether the new plan type works with the Bridge, and check each plan’s 2027 drug list if you take a GLP-1 through Part D for diabetes or another covered use.

Related pages

We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.

Sources

Not medical advice. Medical disclaimer.